SGPP2 and glioblastoma: SGPP1 and SGPL were not examined in the study of Abuhusain and colleagues, therefore we additionally investigated the expression of these S1P degrading enzymes, however we found no significant alterations in GBM tissue and only a tendency of a reduced SGPP2 expression (p = 0.1917).